NCT03639168View on ClinicalTrials.gov

Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

June 24, 2020

Study Completion Date

June 2, 2021

Conditions
Adenoid Cystic CarcinomasCisplatin
Interventions
DRUG

Chidamide combined with cisplatin

Chidamide combined with cisplatin

Trial Locations (1)

200032

Kai Xue, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03639168 - Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC) | Biotech Hunter | Biotech Hunter